This is relevant because both the Haggie and Guidone studies used CF airway cells derived from people homozygous for F508del-CFTR, and as shown by Simonin et al. (13), F508del-CFTR reduced SLC26A4 activity. This evidence concerns the gene CFTR and cystic fibrosis.